News Digging > Lifestyle > U.S. approves Alzheimer’s drug that modestly slows disease
U.S. approves Alzheimer’s drug that modestly slows disease
U.S. approves Alzheimer's drug that modestly slows disease,U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. The Food and Drug Administration approved it for patients with Alzheimer's, specifically those with mild or early-stage disease. Leqembi, from Japan's Eisai and its U.S. partner Biogen, is a rare success in a field accustomed to failed experimental treatments for the incurable condition.

U.S. approves Alzheimer’s drug that modestly slows disease

U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. The Food and Drug Administration approved it for patients with Alzheimer's, specifically those with mild or early-stage disease. Leqembi, from Japan's Eisai and its U.S. partner Biogen, is a rare success in a field accustomed to failed experimental treatments for the incurable condition.